Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Animal Antibiotics and Antimicrobials Market

Animal Antibiotics and Antimicrobials Market Share

  • Report ID: GMI5608
  • Published Date: May 2023
  • Report Format: PDF

Animal Antibiotics and Antimicrobials Market Share

The animal antibiotics and antimicrobials market consists of several players including:

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animal
  • Virbac
  • Vetoquinol
  • Bayer AG
  • Novartis AG
  • Eli Lilly
  • Sanofi
  • Arthrex 

to maintain a competitive edge in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for animal antibiotics & antimicrobials was valued at over USD 4.6 billion in 2022 and is forecasted to reach over USD 6.7 billion by 2032.

The tetracyclines segment accounted for over 42.6% share of the animal antibiotics and antimicrobials market in 2022 and is expected to record robust demand due to its highest potency against pathogenic microorganisms.

The livestock animals segment held a 57.9% market share in 2022 and is projected to expand further driven by rising demand for animal-based products & the introduction of regulations to prevent diseases.

Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Virbac, Vetoquinol, Bayer AG, Novartis AG, Eli Lilly, and Sanofi are some of the leading players in the animal antibiotics and antimicrobials market.

Animal Antibiotics and Antimicrobials Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 357
  • Countries covered: 18
  • Pages: 200
 Download Free Sample